Filing Details
- Accession Number:
- 0001104659-21-022185
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-12 18:00:27
- Reporting Period:
- 2021-02-12
- Accepted Time:
- 2021-02-12 18:00:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1824293 | Vallon Pharmaceuticals Inc. | VLON | Pharmaceutical Preparations (2834) | 824369909 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1844060 | Charles David Baker | C/O Vallon Pharmaceuticals, Inc. 100 N. 18Th Street, Suite 300 Philadelphia PA 19103 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-12 | 7,843 | $6.40 | 7,843 | No | 4 | J | Direct | |
| Common Stock | Acquisiton | 2021-02-12 | 1,000 | $8.00 | 8,843 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | J | Direct | |
| No | 4 | P | Direct |
Footnotes
- Issued immediately prior to the closing of the initial public offering of the issuer's common stock in connection with the conversion of the promissory notes held by the reporting person, as disclosed in the prospectus, dated February 9, 2021, filed with the U.S. Securities and Exchange Commission on February 11, 2021, which forms a part of the Registration Statements on Form S-1 (File Nos. 333-249636 and 333-252925), originally filed on October 23, 2020, as amended.
Billionaire Hedge Funds
